Evidence map›Paper›PMID 40123255›Full record

ArticleArthritis care & research2025

Diverse Treatment Goals in Psoriatic Arthritis: Insights From Participants in the PARC Cohort.

Astia Allenzara, Kathleen Bush, M Elaine Husni, Soumya M Reddy, Jose U Scher, Ethan Craig, Joelle Koplin, Jessica A Walsh, Alexis Ogdie

Abstract read
In one paragraph

Article in Arthritis care & research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Astia AllenzaraUniversity of North Carolina at Chapel Hill.ORCID https://orcid.org/0000-0003-2212-009X
Kathleen BushUniversity of Pennsylvania, Philadelphia.
M Elaine HusniCleveland Clinic, Cleveland, Ohio.ORCID https://orcid.org/0000-0002-3181-4205
Soumya M ReddyNew York University, New York City.
Jose U ScherNew York University, New York City.ORCID https://orcid.org/0000-0002-1072-6994
Ethan CraigUniversity of Pennsylvania, Philadelphia.
Joelle KoplinUniversity of Pennsylvania, Philadelphia.
Jessica A WalshUniversity of Utah, Salt Lake City.ORCID https://orcid.org/0000-0002-4563-0845
Alexis OgdieUniversity of Pennsylvania, Philadelphia.

Funding

Refining Outcome Measurement in Psoriatic Arthritis: Preparation for Pragmatic TrialsR01AR072363 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI OGDIE, ALEXIS R. · 2017 to 2019
$709k
NIAMS NIH HHS R01 AR072363NIH HHS R01-AR-072363
6 · The paper itself

Abstract

objectiveThe aim of this study was to examine patient-reported treatment goals among individuals with psoriatic arthritis.

methodsParticipants in the Psoriatic Arthritis Research Consortium completed standardized assessments, including patient-reported outcome (PROs) instruments, between 2017 and 2020. Additionally, participants were asked two open-ended questions at enrollment or therapy initiation to identify patients' top improvement priority and their treatment impact goals, respectively: "If you could improve one thing about your disease, what would it be?" and "What would an effective treatment change for you?" We categorized each response into a theme. The themes were matched to constructs measured by PRO items (ie, pain, fatigue, skin, etc). We describe themes and scores from matched PRO items.

resultsAssessments were completed by 193 participants. Decreasing pain (56%) and improving skin (12%) were the most common improvement priorities. Impact goals were more diverse and included decreasing pain (24%), general improvement in life (18%), and the ability to be more active (15%), participate in recreational activities (9%), function at work (11%), and exercise (5%). Of note, responses were often matched to more than one PRO item or instrument. The scores for PRO items that matched the patient's improvement priority or the impact goal were higher than scores for the remainder of the population (ie, fatigue item scores were higher among individuals identifying fatigue as their improvement priority).

conclusionThe heterogeneity of treatment goals underscores the importance of eliciting patient treatment goals to guide personalized management. Specific items within PROs may be helpful in identifying and following patient-specific treatment goals.

Identifiers

PMID40123255
PMCPMC12307097

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.